The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index; none of the 167 sources its claims cite is checked for support yet.
IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes‐related foot infections (IWGDF/IDSA 2023)
Open accessAbstract
The International Working Group on the Diabetic Foot (IWGDF) has published evidence‐based guidelines on the management and prevention of diabetes‐related foot diseases since 1999. The present guideline is an update of the 2019 IWGDF guideline on the diagnosis and management of foot infections in persons with diabetes mellitus. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework was used for the development of this guideline. This was structured around identifying clinically relevant questions in the P(A)ICO format, determining patient‐important outcomes, systematically reviewing the evidence, assessing the certainty of the evidence, and finally moving from evidence to the recommendation. This guideline was developed for healthcare professionals involved in diabetes‐related foot care to inform clinical care around patient‐important outcomes. Two systematic reviews from 2019 were updated to inform this guideline, and a total of 149 studies (62 new) meeting inclusion criteria were identified from the updated search and incorporated in this guideline. Updated recommendations are derived from these systematic reviews, and best practice statements made where evidence was not available. Evidence was weighed in light of benefits and harms to arrive at a recommendation. The certainty of the evidence for some recommendations was modified in this update with a more refined application of the GRADE framework centred around patient important outcomes. This is highlighted in the rationale section of this update. A note is also made where the newly identified evidence did not alter the strength or certainty of evidence for previous recommendations. The recommendations presented here continue to cover various aspects of diagnosing soft tissue and bone infections, including the classification scheme for diagnosing infection and its severity. Guidance on how to collect microbiological samples, and how to process them to identify causative pathogens, is also outlined. Finally, we present the approach to treating foot infections in persons with diabetes, including selecting appropriate empiric and definitive antimicrobial therapy for soft tissue and bone infections; when and how to approach surgical treatment; and which adjunctive treatments may or may not affect the infectious outcomes of diabetes‐related foot problems. We believe that following these recommendations will help healthcare professionals provide better care for persons with diabetes and foot infections, prevent the number of foot and limb amputations, and reduce the patient and healthcare burden of diabetes‐related foot disease.
Overview
CoChat Summary
TL;DR
This 2023 IWGDF/IDSA guideline updates recommendations for diagnosing and treating diabetes-related foot infections using GRADE, informed by updated systematic reviews that identified 149 studies (62 new). It emphasizes clinical diagnosis and severity classification, appropriate culture and imaging, pathogen-directed antibiotic therapy, and recommends against several adjunctive or topical treatments.
Key findings
- Diagnosis: diagnose soft-tissue infection clinically and assess severity with the IWGDF/IDSA classification (Strong; Low); consider tissue specimen culture rather than swab (Conditional; Moderate); use conventional rather than molecular microbiology first-line (Strong; Moderate); for osteomyelitis, consider probe-to-bone plus plain X-rays and ESR/CRP/PCT initially (Conditional; Low), MRI if doubt remains (Strong; Moderate), and bone rather than soft-tissue samples for culture (Conditional; Moderate).
- Treatment: for soft-tissue DFI, use any systemic regimen shown effective in RCTs at standard dosing (Strong; High) for 1–2 weeks (Strong; High), possibly up to 3–4 weeks if extensive and resolving slowly or with severe PAD (Conditional; Low); do not treat clinically uninfected ulcers with antibiotics to reduce infection risk or promote healing (Best Practice Statement).
- Osteomyelitis: consider up to 3 weeks of antibiotics after minor amputation with positive bone margin culture and 6 weeks without bone resection or amputation (Conditional; Low); consider surgical resection with systemic antibiotics (Conditional; Low) or antibiotics without surgery for selected forefoot osteomyelitis without immediate drainage need, PAD, or exposed bone (Conditional; Low).
- Adjunctive/topical: suggest not using G-CSF, topical antiseptics, silver preparations, honey, bacteriophage therapy, or negative-pressure wound therapy (Conditional; Low); not using topical antibiotics with systemic antibiotics (Conditional; Low); and not using HBO or topical oxygen therapy solely to treat a DFI (Conditional; Low).
Methods
- GRADE framework was used, structured around P(A)ICO questions, patient-important outcomes, systematic review of evidence, certainty assessment, and moving from evidence to recommendations; a multidisciplinary IWGDF/IDSA working group developed the guideline.
- Two 2019 systematic reviews were updated; 149 studies (62 new) meeting inclusion criteria were identified and incorporated; reviews followed PRISMA and protocols were registered in PROSPERO (CRD42022324795, CRD42022324812).
- Recommendations were discussed and voted on, with a 60% quorum required and majority vote for final decisions; strength was rated strong or conditional and certainty high, moderate, low, or very low.
Limitations
- The paper states many recommendations are conditional with low certainty, and evidence was limited by high risk of bias, inconsistency, imprecision, indirectness, and lack of a definitive criterion standard.
- The paper identifies areas with absent or inconsistent evidence, including rifampicin for diabetes-related foot osteomyelitis, bioactive glass, new antibiotics, molecular microbiology’s impact on management, optimal antibiotic durations, and whether bone biopsy improves outcomes.
- Evident from the text: this is a guideline based on systematic reviews and expert consensus rather than new primary data; the data availability statement says no new data were created or analyzed.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
0 Valid · 2 Not valid · 96 Not checked · 56 Own results and interpretations
In the paper
“However, there is no convincing data (from studies using either conventional culture or molecular methods) supporting this concept.72”
§ IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023) > Rationale
What the sources say
- Not matchedcites [72]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While various imaging tests are widely used for diagnosing bone infection (see below), there are few data on their usefulness for softtissue infections.”
§ IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023) > Rationale
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Due to their limited specificity and sensitivity, not exceeding 0.85, when used as sole diagnostic tools, inflammatory biomarkers should be used when uncertainty persists after clinical assessment.”
§ IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023) > Rationale
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“Insufficient quality of evidence led us to not consider either laboratory risk indicators for necrotising fasciitis or SIRS as reliable tools for predicting lower extremity amputation, mortality, or other health outcomes.52,53”
§ IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023) > Rationale
What the sources say
- Not matchedcites [52]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [53]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, there are no data to support changing from using the systemic inflammatory response syndrome (SIRS) that is part of the IWGDF/IDSA classification to any other classification for DFIs.”
§ IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023) > Rationale
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
69 more claims
Create a free account to see all 154 claims and every source verdict.
- It may state two separate claims as one. 59
- Probably not a substantial claim. 27
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023) > Rationale
“Class 3/4: Moderate/severe Oral/initially iv 2-4 weeks”
§ IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023) > CONFLICT OF INTEREST STATEMENT
“Administer antibiotic therapy to a patient with a skin or soft tissue diabetic foot infection for a duration of 1-2 weeks.(Strong; High).”
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · cited 2×
“35,40 In addition, expert opinion, and aspects relevant to communicating to the reader regarding the intervention or recommendation can be added to these rationales.”
BackgroundPreferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Lipsky, B. A., Berendt, A. R., Cornia, P. B., Pile, J. C., Peters, E. J. G., Armstrong, D. G., Deery, H. G., Embil, J. M., Joseph, W. S., Karchmer, A. W., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis346 · Cited by 1,766
Self-citationDiagnosis and Treatment of Diabetic Foot Infections
Lipsky, B. A., Berendt, A. R., Deery, H. G., Embil, J. M., Joseph, W. S., Karchmer, A. W., LeFrock, J. L., Lew, D. P., Mader, J. T., Norden, C. W., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/424846 · Cited by 1,149
Self-citationSmith, G. B., Prytherch, D. R., Meredith, P., Schmidt, P. E., & Featherstone, P. I. (2013) · Resuscitation · doi:10.1016/j.resuscitation.2012.12.016 · Cited by 1,077
Prompers, L., Schaper, N., Apelqvist, J., Edmonds, M., Jude, E., Mauricio, D., Uccioli, L., Urbancic, V., Bakker, K., Holstein, P., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-0940-0 · Cited by 1,019
Lipsky, B. A., Senneville, É., Abbas, Z. G., Aragón‐Sánchez, J., Diggle, M. A., Embil, J. M., Kono, S., Lavery, L. A., Malone, M., van Asten, S. A. V., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3280 · Cited by 864
Self-citationAlonso-Coello, P., Oxman, A. D., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Vandvik, P. O., Meerpohl, J., et al. (2016) · BMJ · doi:10.1136/bmj.i2089 · Cited by 814 · cited 1×
“35,40 In addition, expert opinion, and aspects relevant to communicating to the reader regarding the intervention or recommendation can be added to these rationales.”
Background
Research works printed but not linked: 7
- International Diabetes Federation, 2021, IDF Diabetes Atlas
- Malone M, 2022, A Systematic review of diagnosis of infection of the diabetic foot (soft tissue and bone): update, PROSPERO
- Malone M, 2022, A Systematic review of Interventions for diabetic foot infections (soft tissue and bone): update, PROSPERO
- Royal College of Physicians, 2012, National Early Warning Score (NEWS). Standardising the Assessment of Acute‐Illness Severity in the NHS
- Peters EJG, 2023, Diagnosis of infection in the foot of patients with diabetes: update 2023 systematic review, Diab Metab Res Rev
- 2017, Pexiganan versus placebo control for the treatment of mild infections of diabetic foot ulcers (OneStep‐2), Clinicaltrialsgov
- 2017, Pexiganan versus placebo control for the treatment of mild infections of diabetic foot ulcers (OneStep‐1), Clinicaltrialsgov
Cited by
Schaper, N. C., van Netten, J. J., Apelqvist, J., Bus, S. A., Fitridge, R., Game, F., Monteiro‐Soares, M., Senneville, E., & the IWGDF Editorial Board (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3657 · Cited by 583
Self-citationGuidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update)
Bus, S. A., Sacco, I. C. N., Monteiro‐Soares, M., Raspovic, A., Paton, J., Rasmussen, A., Lavery, L. A., & van Netten, J. J. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3651 · Cited by 279
Self-citationChen, P., Vilorio, N. C., Dhatariya, K., Jeffcoate, W., Lobmann, R., McIntosh, C., Piaggesi, A., Steinberg, J., Vas, P., Viswanathan, V., et al. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3644 · Cited by 246
Fitridge, R., Chuter, V., Mills, J., Hinchliffe, R., Azuma, N., Behrendt, C., Boyko, E. J., Conte, M. S., Humphries, M., Kirksey, L., et al. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3686 · Cited by 201
12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Callaghan, B. C., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s012 · Cited by 175
Guidelines on offloading foot ulcers in persons with diabetes—IWGDF 2023 update.
Bus, S. A., Armstrong, D. G., Crews, R. T., Gooday, C., Jarl, G., Kirketerp‐Moller, K., Viswanathan, V., & Lazzarini, P. A. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3647 · Cited by 169
Wukich, D. K., Schaper, N. C., Gooday, C., Bal, A., Bém, R., Chhabra, A. B., Hastings, M. K., Holmes, C., Petrova, N. L., Araujo, M. G. S., et al. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3646 · Cited by 129
Self-citationWang, Q., Liu, C., An, J., Liu, J., Wang, Y., & Cai, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1657928 · Cited by 76
Wang, R., Li, B., Dong, M., Zhu, H., Jin, P., & Zou, Y. (2025) · Burns & Trauma · doi:10.1093/burnst/tkaf020 · Cited by 52
Diabetes potentiates the emergence and expansion of antibiotic resistance
Shook, J. C., Genito, C. J., Darwitz, B. P., Tyson, K. J., Velez, A. Z., Bridwell, S., Parsons, J. B., Rowe, S. E., Marshall, C. W., Conlon, B. P., et al. (2025) · Science Advances · doi:10.1126/sciadv.ads1591 · Cited by 41
Yu, P., Chen, L. Y., Chen, Y., Thomas, E. R., Zhou, S., Yang, Y., Liu, K., Wu, J., & Li, X. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1625474 · Cited by 37
Wassif, R. K., Shamma, R. N., Hoffy, N. M. E., & El-Kayal, M. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03172-x · Cited by 35
Ghebrehiwet-Kuflom, J., Mehta, A., Lim, P., Dahle, S. E., & Isseroff, R. R. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2025.08.045 · Cited by 31
Zhang, R., Tan, S. F., Wang, Y., Wu, J., & Zhang, C. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1684357 · Cited by 29
Jamil, E., Saleem, Z., Godman, B., Ullah, M., Amir, A., Haseeb, A., Meyer, J. C., Qamar, M. U., & Abuhussain, S. S. A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1600787 · Cited by 28
Inflammation, diabetic foot and related treatments
Qin, Y., & Deng, S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1676621 · Cited by 26
van Netten, J. J., Apelqvist, J., Bus, S. A., Fitridge, R., Game, F. L., Monteiro‐Soares, M., Senneville, É., & Schaper, N. C. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01510-5 · Cited by 26
Self-citationCoşkun, B., Ayhan, M., Ulusoy, S., & Güner, R. (2024) · Antibiotics · doi:10.3390/antibiotics13070599 · Cited by 25
Yang, M., Deng, B., Hao, W., Jiang, X., Chen, Y., Wang, M., Yuan, Y. C., Chen, M., Wu, X., Du, C., et al. (2025) · Regenerative Therapy · doi:10.1016/j.reth.2025.02.005 · Cited by 25
Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5
Zhang, Q., Zhang, C., Kang, C., Zhu, J., He, Q., Li, H., Tong, Q., Wang, M., Zhang, L., Xiong, X., et al. (2024) · Advanced Science · doi:10.1002/advs.202405987 · Cited by 24
Zhou, G., Tao, Y.-K., Hou, J., Zhu, H., Xiao, L., Zhao, N., Wang, X., Du, B.-L., & Zhang, D. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1543192 · Cited by 23
Guo, H., Xue, Z., Mei, S., Li, T., Yu, H., Ning, T., & Fu, Y. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1521199 · Cited by 22
Shen, K., Zheng, R., Yu, B., Zhang, H., Wang, P., Zhao, P., Chen, J., Yuan, Y., Wang, Y., Wang, K., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.154696 · Cited by 21
Gohil, S. K., Septimus, E. J., Kleinman, K., Varma, N., Sands, K., Avery, T. R., Mauricio, A., Sljivo, S., Rahm, R., Roemer, K., et al. (2025) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2025.0887 · Cited by 20
Machine learning-driven discovery of novel therapeutic targets in diabetic foot ulcers
Yu, X., Wu, Z., & Zhang, N. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00955-z · Cited by 19
Wernecke, J., Wernecke, M., Ebenau, O., Spruth, B., Krämer, M., Vogelmann, T., & Zöllner, Y. F. (2025) · International Wound Journal · doi:10.1111/iwj.70157 · Cited by 18
Castellino, L. M., Crisologo, P. A., Chhabra, A. B., & Öz, O. K. (2025) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2025.02.014 · Cited by 18
Liu, E., Hu, X., Zhang, W., Xiao, W. F., Shen, Y., Luo, Y., Zheng, Z., Zhou, P., He, Y., & Que, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1393251 · Cited by 18
Computer-aided drug design to generate a unique antibiotic family
Barden, C., Wu, F., Fernández-Murray, J. P., Lu, E., Sun, S., Taylor, M. M., Rushton, A. L., Williams, J. G., Tavasoli, M., Meek, A. R., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52797-2 · Cited by 17
Lan, N. S. R., Hiew, J., Ferreira, I., Ritter, J. C., Manning, L. A., Fegan, P. G., Dwivedi, G., & Hamilton, E. J. (2024) · Diabetologia · doi:10.1007/s00125-024-06316-z · Cited by 16
Geng, J., Zhou, G., Guo, S., Wang, G., Ma, J., & Ma, C. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144865 · Cited by 15
Performance of risk prediction models for diabetic foot ulcer: a meta-analysis
Guo, P., Tu, Y., Liu, R., Gao, Z., Du, M., Fu, Y., Wang, Y., Yan, S., & Shang, X. C. (2024) · PeerJ · doi:10.7717/peerj.17770 · Cited by 15
Practical guidelines for the prevention and management of diabetic foot disease in China
Luo, G., Liu, Y., & Wang, A. (2025) · Burns & Trauma · doi:10.1093/burnst/tkaf064 · Cited by 14
Antibiotic and Surgical Treatment of Diabetic Foot Osteomyelitis: The Histopathological Evidence
ROS, R. D., Assaloni, R., Michelli, A., Brunato, B., & Miranda, C. (2024) · Antibiotics · doi:10.3390/antibiotics13121142 · Cited by 14
Integrating Regenerative Medicine in Chronic Wound Management: A Single-Center Experience
Riza, S.-M., Porosnicu, A.-L., Cepi, P.-A., Parasca, S. V., & Sinescu, R. D. (2025) · Biomedicines · doi:10.3390/biomedicines13081827 · Cited by 14
Current challenges in acute bacterial skin infection management
Burillo, A., Pulido-Pérez, A., & Bouza, E. (2024) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000989 · Cited by 14
Guo, H., Xiao, K., Zheng, Y., & Zong, J. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1420136 · Cited by 14
Rashki, S., Haddadi, M. H., Marzhoseyni, Z., Khaledi, M., Yekani, M., Shooraj, M., & Neamati, F. (2025) · Journal of Diabetes Research · doi:10.1155/jdr/6715157 · Cited by 13
Morton, K. E., & Coghill, S. H. (2024) · Antibiotics · doi:10.3390/antibiotics13070594 · Cited by 13
[Practical guideline on the prevention and management of diabetic foot in China (Ⅰ)].
(2025) · PubMed · doi:10.3760/cma.j.cn501225-20250801-00345 · Cited by 13
Winski, R., Xu, J., Townsend, J., Chan, A., Wattengel, B. A., Davis, M., Puckett, A., Huntsman, K., O’Leary, A. L., & Mergenhagen, K. A. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae621 · Cited by 12
Liu, H., Yan, X., Li, G., Wang, B., Wang, D., Zhang, Y.-H., & Guo, J. (2024) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-024-05278-7 · Cited by 12
Cheun, T. J., Hart, J. P., & Davies, M. G. (2024) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2024.11.005 · Cited by 12
Lu, Y., Zhang, B., Wang, Z., He, Y., Ge, H., Ma, H., & Cui, P. (2026) · Marine Drugs · doi:10.3390/md24020076 · Cited by 12
Yao, L.-Y., Zhang, Y., Shen, Y.-Q., Zhang, R.-K., Yang, B., & Deng, C. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114382 · Cited by 11
Idensohn, P., Woodmansey, E. J., Bruwer, F., Cole, W., Günther, B. E., Hoxha, K., Lakshmanan, V., Probst, A., Ramos, P., Smith, G., et al. (2026) · Journal of Wound Care · doi:10.12968/jowc.2026.0302 · Cited by 11
Antimicrobial management of complex biofilms in diabetic foot ulcers: a microbiological perspective
Oliveira, M., Cunha, E. S., Tavares, L. M., & Serrano, I. D. (2025) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2025.2538614 · Cited by 10
Limb Salvage: A review of stem cell and growth factor therapies for diabetic foot ulcers
Metwaly, A., Ismail, S., Nagy, Y. M., Abdallah, A., Hassanin, S. M., Ramadan, K., Nady, A., Melad, L., Mahmoud, M., Abdullah, M. U., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.113036 · Cited by 10
Mitochondria-mediated inflammation and diabetic wound healing: mechanisms and therapeutic strategies
Chen, Y., Li, H., & He, W. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1786693 · Cited by 10
Imaging in osteoarticular infection in adults
Peel, T. N., Cherk, M. H., & Yap, K. S. K. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.11.001 · Cited by 10
The unique multidisciplinarity of diabetes‐related foot disease
van Netten, J. J., Apelqvist, J., Bus, S. A., Fitridge, R., Game, F. L., Monteiro‐Soares, M., Senneville, É., & Schaper, N. C. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3804 · Cited by 10
Self-citationBattle of the Bots: Solving Clinical Cases in Osteoarticular Infections With Large Language Models
Borgonovo, F., Matsuo, T., Petri, F., Amin Alavi, S. M., Mazudie Ndjonko, L. C., Gori, A., & Berbari, E. F. (2025) · Mayo Clinic Proceedings: Digital Health · doi:10.1016/j.mcpdig.2025.100230 · Cited by 10
Mondal, S., Lodh, M., Sahoo, S., Paul, K., Biswas, D., Krishna, C. S. M., Parida, A. K., Ganguly, A., & Dasgupta, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-86013-y · Cited by 9
Arjan, A., Ayesh, B., Abuhalima, D., Taha, A. A., & Zyoud, S. H. (2025) · Scientific Reports · doi:10.1038/s41598-025-33134-z · Cited by 9
Advanced strategies for the management of patients with diabetic foot ulcers: a comprehensive review
Kim, J. M., Kim, C. H., Kang, S. M., Jung, J. H., Kim, K. C., Ahn, S., Park, T. S., & Park, I. B. (2026) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2024.446 · Cited by 9
Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease
Barco, S., Engelberger, R. P., Held, U., Fumagalli, R. M., Grigorean, A., Hayoz, D., Münger, M., Sebastian, T., Stadler, R., Voci, D., et al. (2026) · New England Journal of Medicine · doi:10.1056/nejmoa2600360 · Cited by 9
Doherty, A., Murphy, R. D., Heise, A., Fitzpatrick, F., & Fitzgerald‐Hughes, D. (2024) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001886 · Cited by 9
Reyes, M. C., Suludere, M. A., Tarricone, A. N., Sajjad, T., Coye, T. L., Sideman, M. J., & Lavery, L. A. (2024) · Wound Repair and Regeneration · doi:10.1111/wrr.13215 · Cited by 9
Self-citationFundamentals of wound care for amputation prevention
Almeida, B. M. G. P., Evans, R., & Kayssi, A. (2025) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2025.01.001 · Cited by 9
Lin, J., Huang, L., Li, W., Xiao, H., & Pan, M. (2025) · Biology Direct · doi:10.1186/s13062-025-00672-5 · Cited by 9
Dargan, D. P., Wyman, M., Bhoora, M., Ronan, D., Baker, M., Partridge, D. G., Caddick, J., & Giblin, V. (2024) · Hand · doi:10.1177/15589447241284408 · Cited by 8
Lee, M.-C., Hua, Y., Toh, H. S., Su, H., & Chen, P.-J. (2025) · Diabetes and Vascular Disease Research · doi:10.1177/14791641241311293 · Cited by 8
Bedir, A. S., Almasri, R. S., & Raish, S. M. A. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1592423 · Cited by 8
Overcoming Challenges in Wound Infection: Biofilm and Antimicrobial Resistance
Rothmaier, M., Hardman, M. J., Chatterjee, B., Wilkinson, H. N., Rudden, M., & Frenkel, R. (2026) · Advances in Wound Care · doi:10.1177/21621918261440437 · Cited by 8
Hulshof, C. M., Page, M., van Baal, S. G., Bus, S. A., Fernando, M. E., van Gemert-Pijnen, L., Kappert, K. D. R., Lucadou-Wells, S., Najafi, B., van Netten, J. J., et al. (2024) · Sensors · doi:10.3390/s24082411 · Cited by 8
Trends and prospects in nursing care for diabetic foot: A bibliometric analysis from 2003 to 2023
Zhao, Y., Jing, L., Ma, X., Li, Y., Zhang, J., Li, C., Liu, G., Dai, J., & Cao, S. (2024) · Journal of Tissue Viability · doi:10.1016/j.jtv.2024.07.008 · Cited by 8
Bandeira, M. A., Macedo, R. N., Lázaro‐Martínez, J. L., García‐Álvarez, Y., Rocha, M. N. B., & Santos, V. L. C. D. G. (2024) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346241292377 · Cited by 8
Mo, J., Zhang, J., Meng, X., Wang, F., Tang, W., Liu, Y., Fu, L., Liang, F., & Mo, Z. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s496556 · Cited by 8
Progress in the clinical application of allogeneic platelet-rich plasma for diabetic foot treatment
Qin, H., Yang, H., Wang, J., Jiang, D., Chen, Y., Wang, W., & Wang, A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1694691 · Cited by 7
Wu, B., Lin, S., Xiu, Q., Zhong, M., Huang, Y., Wang, Z., Wu, X., Mei, J., Liu, S., Liu, L., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03918-6 · Cited by 7
Öz, O. K., Sherwood, A., Crisologo, P. A., Killeen, A. L., Bhavan, K., Fontaine, J. L., Rubitschung, K., Hwang, H., Haley, R. W., & Lavery, L. A. (2026) · Diabetologia · doi:10.1007/s00125-025-06652-8 · Cited by 7
Self-citationZhong, J., Tang, Y., Hu, X., Deng, X., Liu, M., Cao, Y., Peng, L., Liu, W., Liu, X., & Deng, L. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.102980 · Cited by 7
Comprehensive Management of Diabetic Foot Ulcers: Current Evidence and Practice
Kim, J. M., Kang, S. M., Jung, J. H., Kim, K. C., Ahn, S., Kim, C. H., Park, T. S., & Park, I. (2026) · Journal of Diabetes · doi:10.1111/1753-0407.70221 · Cited by 7
Tang, Y. C., Hua, J., Yan, Y., Hu, D., Xu, M., Xu, M., Zhao, X., & Chen, M. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5427 · Cited by 7
Development of a clinical metagenomics workflow for the diagnosis of wound infections
Halford, C., Le-Viet, T., Edge, K., Russell, P., Moore, N. A., Trim, F., Moragues-Solanas, L., Lukaszewski, R. A., Weller, S. A., & Gilmour, M. W. (2024) · BMC Medical Genomics · doi:10.1186/s12920-024-02044-w · Cited by 7
Aragón‐Sánchez, J., Víquez‐Molina, G., Uçkay, İ., Rojas‐Bonilla, J. M., & Lipsky, B. A. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2474110 · Cited by 7
Self-citationKadanalı, A., Saltoğlu, N., Ak, Ö., Aktaş, Ş., Altay, F. A., Bayraktaroğlu, T., Bek, N., Bingöl, U. A., Kucuk, B. B., Çayırlı-Güner, M., et al. (2024) · Klimik Dergisi/Klimik Journal · doi:10.36519/kd.2024.4822 · Cited by 7
Uddin, A., Russell, D., Game, F. L., Santos, D., & Siddle, H. J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13113083 · Cited by 7
Zhang, J., Lin, J., Wu, L., & Lin, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1669605 · Cited by 6
Arbona‐Lampaya, A., Pérez-Ojeda, R. A., Santos-Marrero, M., & Perez-Aybar, A. E. (2025) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(25)00720-0 · Cited by 6
Miao, H., Wang, P., Hu, M., Yan, H., Yao, J., You, Q., Dong, W., & Li, L. (2026) · Chinese Chemical Letters · doi:10.1016/j.cclet.2026.112365 · Cited by 6
Moya, M. O. C., Cabrera, L. H., Ramírez, L. M., González, M. A. G., Pazos, A. A., Feitó, L. B. F., & Pernas, G. G. (2026) · SAP Podiatry · doi:10.62486/pod2026160 · Cited by 6
Malone, M., Bergamin, E., Hayashi, K., Schwarzer, S., Dickson, H. G., Lau, N. S., Lavery, L. A., & Commons, R. J. (2024) · Journal of Foot and Ankle Research · doi:10.1002/jfa2.12040 · Cited by 6
Self-citationZhang, F., Yang, C. H., Li, M., Peng, Y. S., Xie, X., Ji, X., & Niu, S. (2025) · Diabetes Therapy · doi:10.1007/s13300-025-01778-9 · Cited by 6
Yasin, P., Dong, S., Aizezi, Z., Yimit, Y., Yusufu, A., Yakufu, M., & Song, X. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-03236-9 · Cited by 6
Not All in Vein: Oral Antibiotics for Diabetic Foot Osteomyelitis: A Narrative Review
Gachet, B., Schechter, M. C., Armstrong, D. G., Robineau, O., & Senneville, É. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14051405 · Cited by 6
Self-citationHon, K. Y., Nobels, F. R. E., Senneville, É., Uçkay, İ., Maas, M. M., & Fitridge, R. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3737 · Cited by 6
Self-citationThe Role of Vitamin C in Wound Healing in Surgically Managed Diabetic Foot Disease
Kancherla, K., Chow, J., Mittal, R., Kaushik, N., Kamal, T., Low, G. K. K., & Martin, B. (2025) · Diabetology · doi:10.3390/diabetology6020009 · Cited by 5
Bayrak, A., Yalın, M., Çiftçi, M. U., Çelik, M., Öztürk, V., & Başaran, S. H. (2025) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346251333835 · Cited by 5
Flores‐Escobar, S., García‐Álvarez, Y., Álvaro‐Afonso, F. J., López‐Moral, M., García‐Madrid, M., & Lázaro‐Martínez, J. L. (2025) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346251332795 · Cited by 5
Ignacyk, M., Krasiński, Z., Michniak‐Kohn, B. B., & Cielecka‐Piontek, J. (2025) · Pharmaceuticals · doi:10.3390/ph18101427 · Cited by 5
Baker, J. C., Northrup, B. E., Ahlawat, S., Allen, H., Allison, G. M., Banks, J., Borloz, M. P., Chamarthy, M. R. K., Garner, H. W., Gross, C. E., et al. (2025) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2025.08.031 · Cited by 5
Self-citationA narrative review of coagulase-negative staphylococci in diabetic foot infections
Magnan, C., Plumet, L., Morsli, M., Dunyach‐Remy, C., Pouget, C., Sotto, A., Molle, V., & Lavigne, J. (2025) · Clinical Microbiology Reviews · doi:10.1128/cmr.00121-25 · Cited by 5
Yao, Y., Huang, M., Li, Y., Lin, Y., Dong, J., Du, J., Zhai, A., Bi, C., & Li, L. (2025) · Small Science · doi:10.1002/smsc.202500482 · Cited by 5
Wang, X., Tian, Y., Zhang, Q., Jin, Y., Shao, C., & Zhang, Z. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1738317 · Cited by 5
Yi-qi, S. H. E. N., Zhang, Y., Yao, L.-Y., Zhang, R.-K., Yang, B., & Deng, C. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04106-w · Cited by 5
Wu, H., Deng, J., Qiu, X., Xu, L. L., Lu, L., Fan, M., Yu, D., Liu, C., Chen, Z., Wang, K., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1667159 · Cited by 5
Quinteros, P. M. T., Gutierrez, L. V. T., & Yovera-Aldana, M. (2024) · ACTA MEDICA PERUANA · doi:10.35663/amp.2024.413.2925 · Cited by 5
Hu, Y., Zhao, Y., Wu, H., Li, X., & Zeng, Q. (2025) · The International Journal of Lower Extremity Wounds · doi:10.1177/15347346241311065 · Cited by 5
Bojke, C., Konwea, H., Nelson, E. A., Brown, S. T., Everett, C., Oates, A., Backhouse, M. R., Collier, H., Dennett, J., Gilberts, R. M., et al. (2025) · Diabetic Medicine · doi:10.1111/dme.15492 · Cited by 5
Metadata
- Authors
- Senneville, É., Albalawi, Z., van Asten, S. A., Abbas, Z. G., Allison, G., Aragón‐Sánchez, J., Embil, J. M., Lavery, L. A., Alhasan, M., Oz, O., Uçkay, I., Urbančič‐Rovan, V., Xu, Z., & Peters, E. J. G.
- Affiliations
- Université de Lille (FR)
- Memorial University of Newfoundland (CA)
- Leiden University (NL)
- Muhimbili University of Health and Allied Sciences (TZ)
- Tufts Medical Center (US)
- Hospital La Paloma (ES)
- University of Manitoba (CA)
- The University of Texas Southwestern Medical Center (US)
- Department of Medicine Prisma Health‐Midlands Columbia South Carolina USA
- UT Southwestern Medical Center Dallas Texas USA
- Balgrist University Hospital Zurich Switzerland
- University of Ljubljana (SI)
- Diabetes Centre Beijing China
- Amsterdam University Medical Centers (NL)
- Corresponding author
- Senneville, Éric
- ORCID
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2023-10
- Volume
- 40
- Issue
- 3
- Pages
- e3687-e3687
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W4387241578
- Cited by
- 498
- References
- 172
- Citations by year
- 2026: 266 · 2025: 176 · 2024: 47 · 2023: 9
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes/Metabolism Research and Reviews (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- Leiden Repository (Leiden University) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Health Sciences › Medicine › Surgery › Orthopedic Infections and Treatments
- Health Sciences › Medicine › Dermatology › Skin Diseases and Diabetes
- Keywords
- diabetic foot, soft tissue infection, bone infection, infection severity classification, microbiological sampling, antimicrobial therapy, empirical treatment, surgical treatment, adjunctive therapy, limb amputation prevention, foot care
- MeSH terms
- Communicable Diseases, Diabetes Mellitus, Foot, Humans, Diabetic Foot
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-13, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-13 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
